Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 4;24(13):2456.
doi: 10.3390/molecules24132456.

Application of Porphyrins in Antibacterial Photodynamic Therapy

Affiliations
Review

Application of Porphyrins in Antibacterial Photodynamic Therapy

Bamidele M Amos-Tautua et al. Molecules. .

Abstract

Antibiotics are commonly used to control, treat, or prevent bacterial infections, however bacterial resistance to all known classes of traditional antibiotics has greatly increased in the past years especially in hospitals rendering certain therapies ineffective. To limit this emerging public health problem, there is a need to develop non-incursive, non-toxic, and new antimicrobial techniques that act more effectively and quicker than the current antibiotics. One of these effective techniques is antibacterial photodynamic therapy (aPDT). This review focuses on the application of porphyrins in the photo-inactivation of bacteria. Mechanisms of bacterial resistance and some of the current 'greener' methods of synthesis of meso-phenyl porphyrins are discussed. In addition, significance and limitations of aPDT are also discussed. Furthermore, we also elaborate on the current clinical applications and the future perspectives and directions of this non-antibiotic therapeutic strategy in combating infectious diseases.

Keywords: antibacterial photodynamic therapy; bacteria; light; nanoparticles; porphyrins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of photodynamic reaction on bacterial cell [30].
Figure 2
Figure 2
(A) Tetraphenylporphyrin and (B) 5,10,15-Tris(p-chlorophenyl)-20-(2-hydroxy-3-methoxyphenyl)-21H,23H-porphyrin.
Figure 3
Figure 3
Absorption spectrum of meso-5,10,15,20-tetrakis(3,5-dimethoxyphenyl)porphyrin in dichloromethane.
Figure 4
Figure 4
Porphyrins found in nature [43].
Figure 5
Figure 5
Structures of porphyrin derivatives. (A) Hematoporphrin (HpD); (B) Chlorin; (C) Bacteriochlorin; (D) Phthalocyanine [47].
Scheme 1
Scheme 1
Synthesis of tetraphenylporphyrin via Rothemund method.
Scheme 2
Scheme 2
Synthesis of Tetraphenylporphyrin via Adler–Longo’s Method.
Scheme 3
Scheme 3
Synthesis of meso-tetraphenylporphyrin via Lindsey’s Method.
Scheme 4
Scheme 4
Synthesis of meso-substituted porphyrins under microwave irradiation.
Scheme 5
Scheme 5
Meso-substituted porphyrin obtained using water as solvent/oxidant microwave irradiation.
Scheme 6
Scheme 6
Synthesis of meso-substituted porphyrins using solid acid catalysts.
Scheme 7
Scheme 7
Synthesis of meso-substituted porphyrins using solventless reaction conditions.
Scheme 8
Scheme 8
Synthesis of meso-substituted porphyrins involving the use of ionic liquids.
Figure 6
Figure 6
Schematic representation of cell wall and cytoplasmic membrane structure in Gram-(−) (left) and Gram-(+) (right) bacteria [12].
Figure 7
Figure 7
Examples of light sources [92].
Figure 8
Figure 8
Structures of TMPyP and ZnTPPS4.
Figure 9
Figure 9
Structures of neutral porphyrins.
Figure 10
Figure 10
Schematic diagram showing the stages involved in carrying out antimicrobial PDT on a burn infection in mice. (A) Inoculation of the mouse with bacterial suspension; (B) injection with photosensitizer solution; (C) irradiation of the infected site with red light [11,77].
Figure 11
Figure 11
Acne treatment with blue light and endogenous, 5-aminolevulinic acid (ALA)-induced porphyrin. Before treatment (A); after six months of therapy (B) [89].
Figure 12
Figure 12
(A) Clinical situation of a patient before antibacterial photodynamic therapy (aPDT). (B) Injection of the photosensitizer. (C) Irradiation with the diode laser. (D) The clinical situation six months after therapy [137].
Figure 13
Figure 13
Structures of some cationic porphyrin derivatives. (A) Tetra-Py+Me; (B) Tri-Py+-Me-CO2H; (C) Tri-Py+-Me-CO2CH3; (D) Tri-Py+-Me-PF4; (E) Di-Py+-Me-Di-CO2H adj; (F) Di-Py+-Me-Di-CO2H opp; (G) Mono-Py+-Me-Tri-CO2H; [142].

Similar articles

Cited by

References

    1. Almeida A., Cunha A., Faustino M.A.F., Tomé A.C., Neves M.G.P.M.S. Porphyrins as Antimicrobial Photosensitizing Agents. In: Hamblin M.R., Jori G., editors. Photodynamic Inactivation of Microbial Pathogens: Medical and Environmental Applications. Volume 11. RSC Publishing; Cambridge, UK: 2011. pp. 83–160.
    1. Maisch T., Hackbarth S., Regensburger J., Felgenträger A., Bäumler W., Landthaler M., Röder B. Photodynamic inactivation of multi resistant bacteria (PIB)–a new approach to treat superficial infections in the 21st century. J. Dtsch. Dermatologischen Ges. 2011;9:360–366. doi: 10.1111/j.1610-0387.2010.07577.x. - DOI - PubMed
    1. Carrel M., Perencevich E.N., David M.Z. USA 300 methicillin-resistant Staphylococcus aureus, United States, 2000–2013. Emerg Infect. Dis. 2015;21:1973–1980. doi: 10.3201/eid2111.150452. - DOI - PMC - PubMed
    1. Pollack A. Rising Threat of Infections Unfazed by Antibiotics, New York Times. [(accessed on 11 November 2018)]; Available online: http://www.biocence.com/download/raging_antibiotic.pdf.
    1. Songca S.P., Oluwafemi O.S. Photodynamic therapy: A new light for the developing world. Afr. J. Biotechnol. 2013;12:3590–3599. doi: 10.5897/AJB12.2586. - DOI